{"anticipatedPostingDate":"2027-12","denomUnitsSelected":"Participants","description":"Dose modification included dose hold, dose reduction, or discontinuation of drugs. Dose reductions or treatment interruption/discontinuation were made at the discretion of the investigator.","reportingStatus":"NOT_POSTED","timeFrame":"From first dose of the study treatment (Day 1) up to the last dose of study treatment (approximately 52.7 months)","title":"Number of Participants With Any Dose Modifications Due to AEs","type":"SECONDARY"}